BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Navas T, Kinders RJ, Lawrence SM, Ferry-Galow KV, Borgel S, Hollingshead MG, Srivastava AK, Alcoser SY, Makhlouf HR, Chuaqui R, Wilsker DF, Konaté MM, Miller SB, Voth AR, Chen L, Vilimas T, Subramanian J, Rubinstein L, Kummar S, Chen AP, Bottaro DP, Doroshow JH, Parchment RE. Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas. Cancer Res 2020;80:304-18. [PMID: 31732654 DOI: 10.1158/0008-5472.CAN-18-3539] [Cited by in Crossref: 15] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lopatina T, Sarcinella A, Brizzi MF. Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion. Cancers (Basel) 2022;14:4020. [PMID: 36011012 DOI: 10.3390/cancers14164020] [Reference Citation Analysis]
2 Xu H, Zhang F, Gao X, Zhou Q, Zhu L. Fate decisions of breast cancer stem cells in cancer progression. Front Oncol 2022;12:968306. [DOI: 10.3389/fonc.2022.968306] [Reference Citation Analysis]
3 Hussein GM, Mohammed SM, Faris M, Mohammed A, Kadhim MJ, Awadh SA, Ajam WH, Jalil AT. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.07.253] [Reference Citation Analysis]
4 Tsavlis D, Katopodi T, Anestakis D, Petanidis S, Charalampidis C, Chatzifotiou E, Eskitzis P, Zarogoulidis P, Porpodis K. Molecular and Immune Phenotypic Modifications during Metastatic Dissemination in Lung Carcinogenesis. Cancers (Basel) 2022;14:3626. [PMID: 35892884 DOI: 10.3390/cancers14153626] [Reference Citation Analysis]
5 Xu Z, Zhang Y, Dai H, Han B. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance. Molecules 2022;27:4750. [PMID: 35897925 DOI: 10.3390/molecules27154750] [Reference Citation Analysis]
6 Hao WW, Xu F. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. World J Gastrointest Oncol 2022; 14(7): 1239-1251 [DOI: 10.4251/wjgo.v14.i7.1239] [Reference Citation Analysis]
7 Song M, Meng Q, Jiang X, Liu J, Xiao M, Zhang Z, Wang J, Bai H. Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway. J Cell Mol Med 2022. [PMID: 35775110 DOI: 10.1111/jcmm.17439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang M, Zhu J, Wang W, Jiang Z. Active legumain promotes invasion and migration of neuroblastoma by regulating epithelial-mesenchymal transition. Open Life Sciences 2022;17:676-85. [DOI: 10.1515/biol-2022-0012] [Reference Citation Analysis]
9 Biller ML, Tuffs C, Bleul M, Tran DT, Dupovac M, Keppler U, Harnoss JM, Probst P, Schneider M, Strowitzki MJ. Effect of Metformin on HIF-1α Signaling and Postoperative Adhesion Formation. J Am Coll Surg 2022;234:1167-80. [PMID: 35703816 DOI: 10.1097/XCS.0000000000000205] [Reference Citation Analysis]
10 Brown MS, Muller KE, Pattabiraman DR. Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside. Cancers (Basel) 2022;14:1138. [PMID: 35267444 DOI: 10.3390/cancers14051138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sonkar C, Varshney N, Koganti S, Jha HC. Kinases and therapeutics in pathogen mediated gastric cancer. Mol Biol Rep 2022. [PMID: 35031925 DOI: 10.1007/s11033-021-07063-9] [Reference Citation Analysis]
12 Liang ZQ, Gao L, Chen JH, Dai WB, Su YS, Chen G. Downregulation of the Coiled-Coil Domain Containing 80 and Its Perspective Mechanisms in Ovarian Carcinoma: A Comprehensive Study. Int J Genomics 2021;2021:3752871. [PMID: 34820451 DOI: 10.1155/2021/3752871] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Liu W, Wang Y, Chen J, Lin Z, Lin M, Lin X, Fan Y. Beneficial Effects of Gracillin From Rhizoma Paridis Against Gastric Carcinoma via the Potential TIPE2-Mediated Induction of Endogenous Apoptosis and Inhibition of Migration in BGC823 Cells. Front Pharmacol 2021;12:669199. [PMID: 34630074 DOI: 10.3389/fphar.2021.669199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Meng X, Yuan H, Li W, Xiao W, Zhang X. Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma. Int J Gen Med 2021;14:5255-67. [PMID: 34522125 DOI: 10.2147/IJGM.S325347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lee YH, Lee MM, De Silva DM, Roy A, Wright CE, Wong TK, Costello R, Olaku O, Grubb RL 3rd, Agarwal PK, Apolo AB, Bottaro DP. Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS One 2021;16:e0241766. [PMID: 34292953 DOI: 10.1371/journal.pone.0241766] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Kummar S, Srivastava AK, Navas T, Cecchi F, Lee YH, Bottaro DP, Park SR, Do KT, Jeong W, Johnson BC, Voth AR, Rubinstein L, Wright JJ, Parchment RE, Doroshow JH, Chen AP. Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors. Invest New Drugs 2021. [PMID: 34180036 DOI: 10.1007/s10637-021-01138-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway. Int J Biol Sci 2021;17:2380-98. [PMID: 34326682 DOI: 10.7150/ijbs.55453] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Ge X, Yao Y, Li J, Li Z, Han X. Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Front Oncol 2021;11:690800. [PMID: 34113574 DOI: 10.3389/fonc.2021.690800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Demény MA, Virág L. The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions. Cancers (Basel) 2021;13:2057. [PMID: 33923319 DOI: 10.3390/cancers13092057] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Saavedra-García P, Roman-Trufero M, Al-Sadah HA, Blighe K, López-Jiménez E, Christoforou M, Penfold L, Capece D, Xiong X, Miao Y, Parzych K, Caputo VS, Siskos AP, Encheva V, Liu Z, Thiel D, Kaiser MF, Piazza P, Chaidos A, Karadimitris A, Franzoso G, Snijders AP, Keun HC, Oyarzún DA, Barahona M, Auner HW. Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs. Proc Natl Acad Sci U S A 2021;118:e2018229118. [PMID: 33883278 DOI: 10.1073/pnas.2018229118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sbiera I, Kircher S, Altieri B, Fassnacht M, Kroiss M, Sbiera S. Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? Cancers (Basel) 2021;13:1736. [PMID: 33917436 DOI: 10.3390/cancers13071736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Kang E, Seo J, Yoon H, Cho S. The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis. Int J Mol Sci 2021;22:3591. [PMID: 33808323 DOI: 10.3390/ijms22073591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zahra FT, Sajib MS, Mikelis CM. Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer. Cancers (Basel) 2021;13:1422. [PMID: 33804681 DOI: 10.3390/cancers13061422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
24 Leggett SE, Hruska AM, Guo M, Wong IY. The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems. Cell Commun Signal 2021;19:32. [PMID: 33691719 DOI: 10.1186/s12964-021-00713-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wei W, Li QG, Long X, Hu GH, He HJ, Huang YB, Yi XL. Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reports. World J Clin Cases 2021; 9(7): 1668-1675 [PMID: 33728311 DOI: 10.12998/wjcc.v9.i7.1668] [Reference Citation Analysis]
26 Zhou HM, Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther 2021;6:62. [PMID: 33589595 DOI: 10.1038/s41392-020-00430-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]
27 Guan Y, Guan A, Chen L, Gong A. LINC00461 facilitates HNSCC development and reduces chemosensitivity by impairing miR-195-mediated inhibition of HOXA10. Mol Ther Oncolytics 2021;21:74-86. [PMID: 33869744 DOI: 10.1016/j.omto.2021.01.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Peyre L, Meyer M, Hofman P, Roux J. TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms. Br J Cancer 2021;124:91-101. [PMID: 33257838 DOI: 10.1038/s41416-020-01177-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, Li Y. Exosomes and breast cancer drug resistance. Cell Death Dis 2020;11:987. [PMID: 33203834 DOI: 10.1038/s41419-020-03189-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
30 Steinbichler TB, Dudas J, Ingruber J, Glueckert R, Sprung S, Fleischer F, Cidlinsky N, Dejaco D, Kofler B, Giotakis AI, Skvortsova II, Riechelmann H. Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer. J Clin Med 2020;9:E2061. [PMID: 32630033 DOI: 10.3390/jcm9072061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Konaté MM, Antony S, Doroshow JH. Inhibiting the Activity of NADPH Oxidase in Cancer. Antioxid Redox Signal 2020;33:435-54. [PMID: 32008376 DOI: 10.1089/ars.2020.8046] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
32 Godin L, Balsat C, Van Eycke YR, Allard J, Royer C, Remmelink M, Pastushenko I, D'Haene N, Blanpain C, Salmon I, Rorive S, Decaestecker C. A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker. Cancers (Basel) 2020;12:E906. [PMID: 32276404 DOI: 10.3390/cancers12040906] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]